Page last updated: 2024-11-12

magnosalin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

magnosalin: from crude Japanese drug Shin-i; inhibits adjuvant-induced angiogenesis & granuloma formation in the mouse pouch; structure given in first source; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10454589
CHEMBL ID156339
CHEBI ID81363
MeSH IDM0190063

Synonyms (11)

Synonym
magnosalin
C17847
1-[2,3-dimethyl-4-(2,4,5-trimethoxyphenyl)-(1r,2r,3r,4r)-cyclobutyl]-2,4,5-trimethoxybenzene
bdbm50110027
chebi:81363 ,
rel-magnosalin
CHEMBL156339 ,
1-[(1r,2r,3r,4r)-2,3-dimethyl-4-(2,4,5-trimethoxyphenyl)cyclobutyl]-2,4,5-trimethoxybenzene
Q27155301
AKOS040762658
81861-74-7
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID684426Cytotoxicity against human A549 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684429Cytotoxicity against human HCT15 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID378128Inhibition of human liver microsome CYP3A4 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID378129Inhibition of human liver microsome CYP2D6 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID684430Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production treated 30 mins before LPS stimulation measured after 24 hrs by Griess reaction2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID99817Relative cytotoxicity measured as inhibition of LPS induced TNF alpha production in L929 cells at 10 uM2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-alpha expression in murine macrophage cell line RAW 264.7.
AID684424Antiinflammatory activity in mouse BV2 cells assessed as inhibition of sodium nitroprusside-induced nitrite accumulation at 10 to 20 uM after 180 mins by Griess reaction2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID147402Tested for the inhibition of nitric oxide syntheses in murine macrophage cell line RAW 264.72002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-alpha expression in murine macrophage cell line RAW 264.7.
AID684425Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM by MTT assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684428Cytotoxicity against human SK-MEL-2 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684432Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced iNOS protein expression at 10 to 20 uM treated 30 mins before LPS stimulation measured after 6 hrs by Western blot analysis2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684427Cytotoxicity against human SKOV3 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.12 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]